Substrate Ablation vs Antiarrhythmic Drug Therapy for Symptomatic Ventricular Tachycardia-Reference-Cited by-同舟云学术

Substrate Ablation vs Antiarrhythmic Drug Therapy for Symptomatic Ventricular Tachycardia

Published:2022-04 Issue:15 Volume:79 Page:1441-1453
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Arenal Ángel,Ávila Pablo,Jiménez-Candil Javier,Tercedor Luis,Calvo David,Arribas Fernando,Fernández-Portales Javier,Merino José Luis,Hernández-Madrid Antonio,Fernández-Avilés Francisco J.,Berruezo Antonio

Funder

European Commission

Medtronic

Instituto de Salud Carlos III

Biosense Webster

Ministerio de Ciencia e Innovación

European Regional Development Fund

Boston Scientific Corporation

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference24 articles.

1. Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator;Moss;Circulation,2004

2. Implantable cardioverter-defibrillators: expanding indicationsand technologies;Goldberger;JAMA,2006

3. Understanding implantable cardioverter defibrillator shocks and storms: medical and psychosocial considerations for research and clinical care;Sears;Clin Cardiol,2003

4. Implantable cardioverter defibrillator recipients: quality of life in recipients with and without ICDshock delivery: a prospective study;Kamphuis;Europace,2003

5. Depression and anxiety status of patients with implantable cardioverter defibrillator and precipitating factors;Bilge;Pacing Clin Electrophysiol,2006

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Systematic Review and Meta-Analysis of Catheter Ablation Versus Anti-arrhythmic Drugs for Treatment of Ventricular Arrhythmia;Cureus;2024-08-24

2. Prognostic value of non-invasive programmed ventricular stimulation after VT ablation to predict VT recurrences;Journal of Interventional Cardiac Electrophysiology;2024-08-16

3. The Current Landscape of Ventricular Tachycardia Trials: A Systematic Review of Registered Studies;Heart, Lung and Circulation;2024-08

4. Catheter ablation compared to medical therapy for ventricular tachycardia in sarcoidosis: nationwide outcomes and hospital readmissions;American Heart Journal Plus: Cardiology Research and Practice;2024-08

5. A randomized clinical trial of catheter ablation and antiarrhythmic drug therapy for suppression of ventricular tachycardia in ischemic cardiomyopathy: The VANISH2 trial;American Heart Journal;2024-08